Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
02/2010
02/04/2010CA2728795A1 Use of steroid sulfatase inhibitors for the treatment of preterm labor
02/03/2010EP2149554A1 Indolyamides as modulators for an EP2 receptor
02/03/2010EP2149371A1 Use of steroid sulfatase inhibitors for the treatment of preterm labor
02/03/2010EP2148694A2 Pharmaceutical agent for the treatment of fertility and gestation disorders, immunological diseases, and transplantation for use in veterinary medicine, particularly in horses, and methods for the production and treatment monitoring thereof
02/03/2010EP1811988B1 Use of acetyl l-carnitine in combination with propionyl l-carnitine and sildenafil for the treatment of erectile dysfunction
02/03/2010EP1301208B1 Mannose as intranasal vaccine adjuvant
02/03/2010CN100586425C Cinnamon poria capsule and its preparation process
02/02/2010US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
02/02/2010US7655674 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell
02/02/2010CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
02/02/2010CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments
01/2010
01/28/2010WO2010011864A2 Alpha-helix mimetic with functionalized pyridazine
01/28/2010US20100021526 Ph modulated films for delivery of actives
01/28/2010US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control
01/28/2010US20100021432 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus
01/28/2010US20100018523 Composition, device, and method for treating sexual dysfunction via inhalation
01/27/2010EP2147922A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
01/27/2010EP1554286B1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
01/27/2010EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor
01/27/2010CN100584374C Externally applied medicine bag for curing chronic pelvic inflammatory disease
01/27/2010CN100584334C Stabled desogestrel medical combination and the preparing method
01/27/2010CN100584321C Vaginal health products
01/26/2010US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents
01/26/2010US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea;
01/26/2010US7651656 Melting furnace with agitator and agitator for melting furnace
01/26/2010CA2505575C 17alpha-hydroxy-14beta-steroids with hormonal effect
01/26/2010CA2468748C Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
01/26/2010CA2447099C Delivery of compounds for the treatment of migraine through an inhalation route
01/26/2010CA2403686C Substituted piperidines as melanocortin receptor agonists
01/26/2010CA2385974C Treating endometriosis or infertility or improving fertility
01/26/2010CA2383250C Phytochemicals for treatment of mastalgia and endometriosis
01/26/2010CA2338854C Nitric esters and nitrate salts of specific drugs
01/21/2010WO2010007629A1 A kit comprising anti-emetic and oral contraceptive
01/21/2010WO2009134383A3 Vinyl substituted fatty acids
01/21/2010WO2009059961A3 A method of hormone suppression in humans
01/21/2010US20100016332 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
01/21/2010US20100016323 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
01/21/2010US20100016290 Amorphous polymorph of bazedoxifene acetate
01/21/2010US20100016266 Pyridine Imidazoles and Aza-indoles as Progesterone Receptor Modulators
01/21/2010US20100016216 Adiponectin and uses thereof
01/21/2010US20100015121 Inhibiting gs-fdh to modulate no bioactivity
01/20/2010EP2145889A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
01/20/2010EP2145884A1 Indoledione derivative
01/20/2010EP2145629A2 Use of neurotoxin therapy for treatment of urologic and related disorders
01/20/2010EP2145615A1 Skin-lightening agent containing equol compound as active ingredient
01/20/2010EP2032123B1 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
01/20/2010EP1506214B1 6-11 bicyclic ketolide derivatives
01/20/2010EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators
01/20/2010EP1313422B1 Non-hormonal vaginal contraceptive
01/20/2010EP1028708B1 Topical compositions for prostaglandin e1 delivery
01/20/2010CN100581569C Production of drop-pill preparation in treatment of pelvic inflammatory disease
01/20/2010CN100581568C Production of slow-releasing capsule in treatment of pelvic inflammatory disease
01/20/2010CN100581567C Vaginitis lotion preparation method
01/20/2010CN100581550C Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
01/20/2010CN100581544C Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction
01/20/2010CN100581541C Utilization of extracts from racemosa rhizoma for producing estrogen-like organ-selective medicament for suppressing LHSP activity
01/19/2010US7649001 Fused benzene derivative and use
01/19/2010US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine
01/19/2010US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine.
01/19/2010CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
01/19/2010CA2366911C Compositions for improving fertility
01/14/2010WO2010004005A1 Compositions that aim to promote the development and growth of a beneficial vaginal microflora
01/14/2010US20100010061 Cb1 receptor modulators
01/14/2010US20100010004 Inhibitors of histone deacetylase
01/14/2010US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
01/14/2010US20100008951 Flu vaccine admixture of mannan and flu antigen
01/13/2010EP2143719A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity
01/13/2010EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery
01/13/2010EP2142186A1 Use of oligomers of lactic acid in the treatment of gynaecological disorders
01/13/2010EP2142175A2 Pharmaceutical compositions of diclofenac and misoprostol
01/13/2010EP1793840B1 The use of winter savory ( satureja montana ) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
01/13/2010EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
01/13/2010CN100579568C Oral Chinese-medicinal composition for treating difficult menstruation
01/13/2010CN100579566C Chinese-medicinal coated tablets for treating gynecological and preparation thereof
01/13/2010CN100579552C Chinese patent medicine for treating aspermia or oligospermia and method of preparing the same
01/13/2010CN100579540C Medicine compound for preventing and treating gynecopathy such as pelvic inflammatory disease
01/13/2010CN100579516C Vaginal effervescence tablet composition containing solid lipid
01/12/2010US7645779 Linked biaryl compounds
01/12/2010US7645765 With water miscible solubilizer; phosphodiesterase inhibitors; cardiovascular disorders
01/12/2010US7645761 Indoline derivatives
01/12/2010CA2483678C 6-11 bicyclic ketolide derivatives
01/12/2010CA2468412C 17.alpha.-alkyl-17.beta.-oxy-estratrienes and intermediates for their production, use of the 17.alpha.-alkyl-17.beta.-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations
01/12/2010CA2438143C Modified proteins, designer toxins, and methods of making thereof
01/12/2010CA2409664C Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
01/12/2010CA2407838C Pyrano, piperidino, and thiopyrano compounds and methods of use
01/12/2010CA2403514C 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
01/12/2010CA2293731C Disulfide cross-linking glycoprotein hormone analogs, and their preparation and use
01/07/2010WO2010001258A2 Inhibition of tumour growth and metastases
01/07/2010WO2010000943A1 An intrauterine delivery system for contraception
01/07/2010US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
01/07/2010US20100004196 Heparan sulfate proteoglycan composition and use thereof
01/07/2010CA2730040A1 An intrauterine delivery system for contraception
01/06/2010EP2141150A1 Bicyclic compound and pharmaceutical use thereof
01/06/2010EP2141148A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
01/06/2010EP2139994A2 2786, a human aminopeptidase
01/06/2010EP2139896A1 Pyrimido [4, 5-d]azepine derivatives as 5-ht2c agonists
01/06/2010EP1773338B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
01/06/2010EP1575938B1 Compounds having selective inhibiting effect at gsk3
01/06/2010EP1558265B1 Use of drospirenone for the treatment of hypertension
01/06/2010EP1513831B1 Novel compounds, their use and preparation